Sackler Family Sackler Family
Stories About

Sackler Family

Just Stop Oil activists glue their hands to the wall after throwing soup at Vincent van Gogh's "Sunflowers" at the National Gallery in London earlier this month. Museums and famous artworks have long been the site of public protests. Just Stop Oil/Reuters hide caption

toggle caption
Just Stop Oil/Reuters

Family members exchange photographs of their lost loved ones in the lobby of the Akin Gump law firm offices on Thursday in Manhattan, NY. The family members and victims gave statements to the U.S. Bankruptcy Court with the Sackler family, who own Purdue Pharma LP, present on Thursday. Desiree Rios for NPR hide caption

toggle caption
Desiree Rios for NPR

For the first time, victims of the opioid crisis formally confront the Sackler family

  • Download
  • <iframe src="https://www.npr.org/player/embed/1085174528/1085887668" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Cars pass Purdue Pharma headquarters in Stamford, Conn. A federal mediator said in a filing Friday that Purdue's owners are willing to increase their offer for a settlement in lawsuits over the toll of opioids. Frank Franklin II/AP file photo hide caption

toggle caption
Frank Franklin II/AP file photo

Demonstrators scatter fake money and prescription bottles of OxyContin in August outside of U.S. Bankruptcy Court in White Plains, where the Purdue bankruptcy hearings were held. Erik McGregor/LightRocket via Getty Images hide caption

toggle caption
Erik McGregor/LightRocket via Getty Images

The Purdue Pharma Deal Would Deliver Billions, But Individual Payouts Will Be Small

  • Download
  • <iframe src="https://www.npr.org/player/embed/1040447650/1041408774" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Purdue Pharma filed for bankruptcy with a more than $10 billion plan to settle claims that it fueled the U.S. opioid epidemic by illegally pushing sales of its addictive OxyContin painkiller. The company's headquarters in Stamford, Conn., is shown here in 2019. Victor J. Blue/Bloomberg/Getty Images hide caption

toggle caption
Victor J. Blue/Bloomberg/Getty Images

Two demonstrators protest against U.S. Judge Robert Drain, who has granted immunity from future opioid lawsuits to members of the Sackler family. Brian Mann hide caption

toggle caption
Brian Mann

The Sacklers, Who Made Billions From OxyContin, Win Immunity From Opioid Lawsuits

  • Download
  • <iframe src="https://www.npr.org/player/embed/1031053251/1033568603" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

David and Kathe Sackler, members of the family that owns Purdue Pharma, the maker of OxyContin, testified via video to a House Oversight Committee hearing on Dec. 17, 2020. Sackler family members have acknowledged that the drug had a role in the opioid crisis, but they have stopped short of apologizing or admitting wrongdoing. House Television via AP hide caption

toggle caption
House Television via AP

The Sacklers Want Immunity From The Opioid Crisis For A Long List Of Their Associates

  • Download
  • <iframe src="https://www.npr.org/player/embed/1028761427/1029582468" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Signage for Purdue Pharma headquarters stands in downtown Stamford, April 2, 2019 in Stamford, Connecticut. Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family, are facing hundreds of lawsuits across the country for the company's alleged role in the opioid epidemic that has killed more than 200,000 Americans over the past 20 years. Drew Angerer/Getty Images hide caption

toggle caption
Drew Angerer/Getty Images

As Purdue Pharma Bankruptcy Nears Approval, Family Members Write About The Human Toll

  • Download
  • <iframe src="https://www.npr.org/player/embed/1025171160/1026004366" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A 2013 file photo shows OxyContin pills at a pharmacy in Montpelier, Vt. Toby Talbot/AP hide caption

toggle caption
Toby Talbot/AP

Justice Department Blasts Purdue Pharma's Bankruptcy Plan

  • Download
  • <iframe src="https://www.npr.org/player/embed/1018028179/1018523914" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Purdue Pharma faced an avalanche of lawsuits for alleged harm caused by its prescription opioid medicine OxyContin. A controversial bankruptcy deal expected to be finalized next month would block lawsuits against members of the Sackler family who own the firm. Darren McCollester/Getty Images hide caption

toggle caption
Darren McCollester/Getty Images

Members of the Sackler family who own Purdue Pharma, the maker of OxyContin, moved a step closer to winning immunity from opioid lawsuits. Erik McGregor/LightRocket via Getty Images hide caption

toggle caption
Erik McGregor/LightRocket via Getty Images

Sackler Family Empire Poised To Win Immunity From Opioid Lawsuits

  • Download
  • <iframe src="https://www.npr.org/player/embed/1002085031/1002604478" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

David (left) and Kathe Sackler, members of the family that owns Purdue Pharma, the maker of Oxycontin, testified via video to a House Oversight Committee hearing on Dec. 17, 2020. Sackler family members have acknowledged that the drug had a role in the opioid crisis, but they have stopped short of apologizing or admitting wrongdoing. House Television via AP hide caption

toggle caption
House Television via AP

24 States Mount Legal Fight To Block Sackler Bid For Opioid Immunity

  • Download
  • <iframe src="https://www.npr.org/player/embed/991648432/992993686" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A federal judge extended a block on lawsuits against members of the Sackler family, owners of Purdue Pharma, until April 21. The drug-maker filed for bankruptcy in 2019, facing an avalanche of claims linked to the marketing and sale of its highly addictive painkiller OxyContin. Toby Talbot/AP hide caption

toggle caption
Toby Talbot/AP

Purdue Pharma, maker of the highly addictive OxyContin, is keeping secret the results of an investigation of the Sacklers. Critics want the findings made public. Drew Angerer/Getty Images hide caption

toggle caption
Drew Angerer/Getty Images

Purdue Pharma Conducted Massive Probe Of The Sacklers, But The Findings Are Secret

  • Download
  • <iframe src="https://www.npr.org/player/embed/978540184/979340123" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

OxyContin pills arranged at a pharmacy in Montpelier, Vt. Purdue Pharma makes the highly addictive drug. Toby Talbot/AP hide caption

toggle caption
Toby Talbot/AP

Purdue Pharma Offers Restructuring Plan, Sackler Family Would Give Up Ownership

  • Download
  • <iframe src="https://www.npr.org/player/embed/977378745/977712287" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tufts employee Gabe Ryan removes the Sackler family name from a building at Tufts University, the first major university to strip the Sackler name from buildings and programs. Boston Globe via Getty Images hide caption

toggle caption
Boston Globe via Getty Images

Sacklers Deny Wrongdoing During House Panel Over Purdue Pharma Oxycontin Sales

  • Download
  • <iframe src="https://www.npr.org/player/embed/947064266/947693909" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Drew Angerer/Getty Images

McKinsey Apologizes For Helping Purdue Pharma 'Turbocharge' Opioid Sales

  • Download
  • <iframe src="https://www.npr.org/player/embed/944563257/944739818" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Newly public documents detail the role of members of the Sackler family, owners of OxyContin maker Purdue Pharma, during years when the privately owned drug company launched criminal schemes designed to "turbocharge" sales of Oxycontin and other highly addictive opioid medications. Toby Talbot/AP hide caption

toggle caption
Toby Talbot/AP

Critics Want Sacklers To Face Criminal Charges For Role In Opioid Crisis

  • Download
  • <iframe src="https://www.npr.org/player/embed/938801514/938901348" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Purdue Pharma headquarters in Stamford, Conn., in 2019. Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family, have faced hundreds of lawsuits over the company's alleged role in the opioid epidemic that has killed more than 200,000 Americans. Drew Angerer/Getty Images hide caption

toggle caption
Drew Angerer/Getty Images

Purdue Pharma Reaches $8B Opioid Deal With Justice Department Over OxyContin Sales

  • Download
  • <iframe src="https://www.npr.org/player/embed/926126877/926352388" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tufts University stripped the Sackler name from several of its buildings and divisions earlier this month, citing the billionaire family's role in the opioid crisis. The founders of Purdue Pharma have come under intense scrutiny for how their company misled doctors and patients about the addictiveness of its signature medication. Steven Senne/AP hide caption

toggle caption
Steven Senne/AP